Abstract

The process of drug discovery is challenging and a costly affair. It takes about 12 to 15 years and costs over $1 billion dollars to develop a new drug and introduce the finished product in the market. With the increase in diseases, virus spread, and patients, it has become essential to invent new medicines. Consequently, today researchers are becoming interested in inventing new medicines faster by adopting higher throughput screening methods. One avenue of approach to discovering drugs faster is the High-Throughput Screening (HTS) method, which has gained a lot of attention in the previous few years. Today, High-Throughput Screening (HTS) has become a standard method for discovering drugs in various pharmaceutical industries. This review focuses on the advancement of technologies in High-Throughput Screening (HTS) methods, namely fluorescence resonance energy transfer (FRET), biochemical assay, fluorescence polarization (FP), homogeneous time resolved fluorescence (HTRF), Fluorescence correlation spectroscopy (FCS), Fluorescence intensity distribution analysis (FIDA), Nuclear magnetic resonance (NMR), and research advances in three major technology areas including miniaturization, automation and robotics, and artificial intelligence, which promises to help speed up the discovery of medicines and its development process.

Highlights

  • It takes about 12 to 15 years and costs over $1 billion dollars to develop a new drug and introduce the finished product in the market

  • This review highlights the types of High-throughput screening assays and different detection techniques such as fluorescence resonance energy transfer (FRET), biochemical assay, fluorescence polarization (FP), homogeneous time resolved fluorescence (HTRF), Fluorescence correlation spectroscopy (FCS), Fluorescence intensity distribution analysis (FIDA) [6], Nuclear magnetic resonance (NMR), and research advances in three major technology areas including miniaturization, automation and robotics, and artificial intelligence, which has shown great promise to speed the discovery of medicines and its development process [7, 8]

  • The HTRF method is a combination of time resolved measurement (TR) of fluorescence and standard FRET technology, thereby allowing the elimination of shortlived background Fluorescence, which occurs due to interfering materials in the sample and allowing a delay of approximately 50 to 150μseconds between the initial excitation and fluorescence measurement

Read more

Summary

Introduction

It takes about 12 to 15 years and costs over $1 billion dollars to develop a new drug and introduce the finished product in the market. The High-throughput screening method screens millions of chemical and biological compounds in a short interval of time It is an automated process and screens many biological or chemical compounds for their therapeutic potential. The. High-throughput screening method efficiently accelerates the discovery of drugs, which are of potentially great therapeutic promise compared with other screening methods [3–5]. This review highlights the types of High-throughput screening assays and different detection techniques such as fluorescence resonance energy transfer (FRET), biochemical assay, fluorescence polarization (FP), homogeneous time resolved fluorescence (HTRF), Fluorescence correlation spectroscopy (FCS), Fluorescence intensity distribution analysis (FIDA) [6], Nuclear magnetic resonance (NMR), and research advances in three major technology areas including miniaturization, automation and robotics, and artificial intelligence, which has shown great promise to speed the discovery of medicines and its development process [7, 8]

Understanding high-throughput screening process for the discovery of drugs
In screening
Test of mixture in solutions
Test of individual compounds in solutions
Test compounds on the beads
Applications
Homogeneous assay
Heterogeneous assays
Biochemical assays
Fluorescence resonance energy transfer (FRET)
Fluorescence polarization (FP)
Applications i
Homogeneous time resolved fluorescence (HTRF)
Fluorescence correlation spectroscopy (FCS)
2.10 Fluorescence intensity distribution analysis (FIDA)
2.11 Nuclear magnetic resonance (NMR)
Second messenger assays
Reporter gene assays
Statistics
Automation and robotics
Miniaturization
Artificial intelligence
Conclusions
Executive summary
Findings
Future directions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.